Examining the effect of 5-HTTLPR on depressive symptoms in postmenopausal women 1 year after initial breast cancer treatment
Depression following the diagnosis of breast cancer has been well documented, and occurs in as many as 40% of women. The serotonin transporter gene SLC6A4 and its functional polymorphism 5-HTTLPR have been extensively studied as factors in the development of depression. Many research studies have demonstrated conflicting results, and the contribution of 5-HTTLPR to depression is unclear.
The purpose of this study was to compare the relationship between depressive symptoms and serotonin transporter gene polymorphisms between women with early-stage breast cancer 1 year following initial diagnosis and surgery and matched controls.
Participants (N = 125), included postmenopausal women following breast cancer surgery (n = 80) and age-and education-matched healthy controls (n = 45). The genetic elements of interest were the long (LA) and short (S) alleles of 5-HTTLPR, as well as the single nucleotide polymorphism rs25531 A > G within the L-allele (LG). DNA was extracted from either blood or saliva and analyzed for the SLC6A4 polymorphisms. The outcome measures for this longitudinal study included Beck Depression Inventory scores and physical function domain scores from the Medical Outcome Study Short Form 36. Results: Women with breast cancer demonstrated greater depressive symptomatology and decreased physical function compared to healthy controls. The LA/LA genotype was associated with increased depressive symptomatology in the overall sample and within the controls. The LA/LA genotype appeared with greater frequency in the experimental group, but the relationship with increased depressive symptoms was not observed. Physical function was a significant (p < 0.00) predictor of depressive symptoms in both groups at 12 months.
The relationship between 5-HTTLPR and depressive symptomatology in breast cancer patients remains unclear. A potential clinical application includes monitoring physical function and addressing increased depressive symptoms as physical function declines.
KeywordsBreast cancer 5-HTTLPR Depressive symptoms Physical function
This study was supported by the National Cancer Institute, the National Institute of Nursing Research and the Oncology Nursing Foundation. All primary data are housed at the University of Pittsburgh School of Nursing, and are available on request.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.American Cancer Society, (2017). Breast Cancer Facts and Figures 2017.1/31/2017; Available from: http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-key-statistics
- 6.Wickham R (2004) Cancer symptom-management. Jones and Bartlett Learning, BurlingtonGoogle Scholar
- 8.Gonda X, Eszlari N, Kovacs D, Anderson IM, Deakin JF, Juhasz G, Bagdy G (2016) Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms. Transl Psychiatry 6:e798. https://doi.org/10.1038/tp.2016.57 PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Mandorfer M, Payer BA, Scheiner B, Breitenecker F, Aichelburg MC, Grabmeier-Pfistershammer K, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T (2014) Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver Int 34(1):69–77PubMedCrossRefGoogle Scholar
- 14.Banovic I, Gilibert D, Cosnes J (2010) Crohn’s disease and fatigue: constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. BMC Psychol 15(4):394–405Google Scholar
- 23.Rao S, Leung CS, Lam MH, Wing YK, Waye MM, Tsui SK (2017) Resequencing three candidate genes discovers seven potentially deleterious variants susceptibility to major depressive disorder and suicide attempts in Chinese. Gene 603:34–41. https://doi.org/10.1016/j.gene.2016.12.006 PubMedCrossRefGoogle Scholar
- 25.Manoharan A, Shewade DG, Rajkumar RP, Adithan S (2016) Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients. Eur J Clin Pharmacol 72(10):1215–1220. https://doi.org/10.1007/s00228-016-2099-9 PubMedCrossRefGoogle Scholar
- 33.Taylor AE, Munafo MR (2016) (2016). Triangulating meta-analyses: the example of the serotonin transporter gene, stressful life events and major depression. Psychol Health Med 4(1):23Google Scholar
- 36.Klein, M., et al. (2001). Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. [summary for patients in Curr Neurol Neurosci Rep 2002 May;2(3):203–4; PMID: 11936997]. J Clin Oncol, 19(20): 4037–47Google Scholar